PUBLIC COMPANY
save$BBIOBridgeBio Pharma, Inc.
$BBIO81.21-3.14%Palo Alto, CA, USupdated 13h ago
community read0 votes
pipeline
2
marketed
1
phase 3
1
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 31Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 10, 26SELLKumar Neil· Chief Executive Officer−$1.49M↗
- Apr 10, 26SELLKumar Neil· Chief Executive Officer−$1.49M↗
- Apr 9, 26SELLKumar Neil· Chief Executive Officer−$589K↗
- Apr 9, 26SELLKumar Neil· Chief Executive Officer−$567K↗
- Apr 9, 26SELLKumar Neil· Chief Executive Officer−$530K↗
- Apr 9, 26SELLKumar Neil· Chief Executive Officer−$521K↗
- Apr 9, 26SELLKumar Neil· Chief Executive Officer−$395K↗
- Apr 9, 26SELLKumar Neil· Chief Executive Officer−$382K↗
- Mar 13, 26SELLKumar Neil· Chief Executive Officer−$713K↗
- Mar 13, 26SELLKumar Neil· Chief Executive Officer−$700K↗
- Mar 13, 26SELLKumar Neil· Chief Executive Officer−$676K↗
- Mar 13, 26SELLKumar Neil· Chief Executive Officer−$662K↗
- Mar 12, 26SELLKumar Neil· Chief Executive Officer−$982K↗
- Mar 12, 26SELLKumar Neil· Chief Executive Officer−$951K↗
- Mar 12, 26SELLKumar Neil· Chief Executive Officer−$403K↗
- Mar 12, 26SELLKumar Neil· Chief Executive Officer−$372K↗
- Mar 12, 26SELLKumar Neil· Chief Executive Officer−$21K↗
- Mar 12, 26SELLKumar Neil· Chief Executive Officer−$21K↗
- Mar 10, 26SELLValantine Hannah· director−$624K↗
- Mar 4, 26SELLEllis Andrea· director−$4.21M↗
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that